Intervention Protocol

You have free access to this content

High flow nasal cannula for respiratory support in term infants

  1. Sara Mayfield1,2,3,*,
  2. Jacqueline Jauncey-Cooke1,2,3,
  3. Andreas Schibler1,3,
  4. Judith L Hough1,3,4,
  5. Fiona Bogossian2

Editorial Group: Cochrane Neonatal Group

Published Online: 4 MAR 2014

Assessed as up-to-date: 21 FEB 2014

DOI: 10.1002/14651858.CD011010

How to Cite

Mayfield S, Jauncey-Cooke J, Schibler A, Hough JL, Bogossian F. High flow nasal cannula for respiratory support in term infants (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No.: CD011010. DOI: 10.1002/14651858.CD011010.

Author Information

  1. 1

    Mater Children’s Hospital, Paediatric Critical Care Research Group, South Brisbane, Queensland, Australia

  2. 2

    School of Nursing and Midwifery, The University of Queensland, Herston, Australia

  3. 3

    Mater Research Institute, South Brisbane, Australia

  4. 4

    Australian Catholic University, School of Physiotherapy, Banyo, Australia

*Sara Mayfield,

Publication History

  1. Publication Status: New
  2. Published Online: 4 MAR 2014




  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the safety and efficacy of high flow nasal cannula oxygen therapy for respiratory support in term infants. We will compare HFNC with other forms of non-invasive support including:

  • low flow nasal cannula oxygen
  • head box oxygen
  • nasal continuous positive airway pressure
  • non-invasive positive pressure ventilation
  • alternative forms of HFNC (such as non humidified or humidified)

Subgroup analysis will be undertaken to determine efficacy of HFNC in term infants with different underlying conditions. These conditions include congestive heart failure, pneumonia/pneumonitis (aspiration, bacterial, or viral)